ES2099272T3 - Composiciones oftalmicas a base de oxicam o de derivados de oxicam. - Google Patents

Composiciones oftalmicas a base de oxicam o de derivados de oxicam.

Info

Publication number
ES2099272T3
ES2099272T3 ES92916114T ES92916114T ES2099272T3 ES 2099272 T3 ES2099272 T3 ES 2099272T3 ES 92916114 T ES92916114 T ES 92916114T ES 92916114 T ES92916114 T ES 92916114T ES 2099272 T3 ES2099272 T3 ES 2099272T3
Authority
ES
Spain
Prior art keywords
oxicam
compositions
ophthalmic compositions
compositions based
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92916114T
Other languages
English (en)
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPHTA LAB
Original Assignee
EUROPHTA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPHTA LAB filed Critical EUROPHTA LAB
Application granted granted Critical
Publication of ES2099272T3 publication Critical patent/ES2099272T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION CONCIERNE A NUEVAS COMPOSICIONES FARMACEUTICAS DESTINADAS AL USO OFTALMICO. CONCIERNE EN PARTICULAR A COMPOSICIONES OFTALMICAS INSTILABLES DE VISCOSIDAD MEDIA CARACTERIZADAS EN QUE CONTIENEN COMO PRINCIPIO ACTIVO UN AGENTE ANTIINFLAMATORIO ASOCIADO EVENTUALMENTE A UN AGENTE ANTIBACTERIANO Y A UN POLIMERO DE ACIDO ACRILICO CONGELANTE Y UN AGENTE BASICO DE MANERA QUE OBTENGA SOLUTO ACUOSO, FLUIDO, QUE TIENE UN PH COMPRENDIDO ENTRE 7,0 Y 8,0. LAS COMPOSICIONES SEGUN LA INVENCION SON UTILES PARA EL TRATAMIENTO DE LAS MANIFESTACIONES INFLAMATORIAS PATOLOGICAS DE LA ESFERA OCULAR.
ES92916114T 1991-07-18 1992-07-17 Composiciones oftalmicas a base de oxicam o de derivados de oxicam. Expired - Lifetime ES2099272T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109096A FR2679135B1 (fr) 1991-07-18 1991-07-18 Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.

Publications (1)

Publication Number Publication Date
ES2099272T3 true ES2099272T3 (es) 1997-05-16

Family

ID=9415269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92916114T Expired - Lifetime ES2099272T3 (es) 1991-07-18 1992-07-17 Composiciones oftalmicas a base de oxicam o de derivados de oxicam.

Country Status (10)

Country Link
EP (1) EP0594770B1 (es)
AT (1) ATE147627T1 (es)
AU (1) AU2388392A (es)
DE (1) DE69216831T2 (es)
DK (1) DK0594770T3 (es)
ES (1) ES2099272T3 (es)
FI (1) FI107700B (es)
FR (1) FR2679135B1 (es)
NO (1) NO940160L (es)
WO (1) WO1993001814A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004876A1 (es) * 2003-07-10 2005-01-20 Arturo Jimenez Bayardo Metodo para preparar una solucion acuosa de meloxicam y solucion acuosa resultante

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
NZ502990A (en) * 1997-08-27 2002-02-01 Hexal Ag Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
JP4234907B2 (ja) * 1998-05-15 2009-03-04 わかもと製薬株式会社 抗炎症点眼剤
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
KR101433152B1 (ko) * 2006-12-22 2014-08-22 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 안과용 약물의 전달에 유용한 젤
MX2012004177A (es) 2009-10-12 2012-05-08 Boehringer Ingelheim Vetmed Recipiente para composiciones que comprenden meloxicam.
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
JPS5913714A (ja) * 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004876A1 (es) * 2003-07-10 2005-01-20 Arturo Jimenez Bayardo Metodo para preparar una solucion acuosa de meloxicam y solucion acuosa resultante

Also Published As

Publication number Publication date
FI107700B (fi) 2001-09-28
DK0594770T3 (da) 1997-07-21
DE69216831T2 (de) 1997-07-31
ATE147627T1 (de) 1997-02-15
FR2679135B1 (fr) 1995-05-19
FI940224A (fi) 1994-03-14
NO940160L (no) 1994-03-04
FR2679135A1 (fr) 1993-01-22
DE69216831D1 (de) 1997-02-27
NO940160D0 (no) 1994-01-17
WO1993001814A1 (fr) 1993-02-04
FI940224A0 (fi) 1994-01-17
AU2388392A (en) 1993-02-23
EP0594770A1 (fr) 1994-05-04
EP0594770B1 (fr) 1997-01-15

Similar Documents

Publication Publication Date Title
ES2099272T3 (es) Composiciones oftalmicas a base de oxicam o de derivados de oxicam.
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
BE847686A (fr) Corps d'insertion oculaire pour le traitement de la siccite oculaire par deficience aqueuse,
DE69023574T2 (de) Amphotere Zusammensetzungen und Polymerformen von alpha-Hydroxy-Säuren, und ihre therapeutische Anwendung.
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
AR024380A1 (es) Tienopirimidinas
ATE215821T1 (de) Entzündungshemmende augentropfen
DE69419640D1 (de) Pharmakologische Verwendung von 5-Aminophthaloylhydrazide; ihre Zusammensetzung und Anwendung
DK0549666T3 (da) Nye aminobenzosultamderivater og deres anvendelse som lipoxygenaseinhibitorer
DK0560730T3 (da) Aminosyrederivater med antithrombotisk virkning
FI940081A0 (fi) Polyakryylihappopohjaisia silmätulehduksenvastaisia koostumuksia
SE8801710L (sv) New ophtalmological composition of matter
NO940064L (no) Öyepreparat på polyakrylsyrebasis
MC2217A1 (fr) Procede de preparation d'une composition pharmaceutique a usage optalmologique contenant de l'hexetidine ou ses derives ou sels
ES2060103T3 (es) Polimeros hidrofilos anfolitos, su procedimiento de preparacion, y su empleo como agentes absorbentes.
DE69115890D1 (de) Sterilisierende zusammensetzung
RU93015155A (ru) Лекарственное средство для лечения дистрофических заболеваний и травм глазных тканей

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 594770

Country of ref document: ES